Issue 138 | January 2024
Pharma’s path to Net Zero: Targeting Scope 3 emissions
In this issue: Pharma’s efforts to curb Scope 3 emissions, understanding European Pharmaceutical legislation, predicting the future of cell and gene therapy manufacturing, and looking back at the pharma industry’s performance in 2023.